Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.

Clinical trial NCT00928304 · COMPLETED

Trial details

NCT number: NCT00928304
Sponsor: Lantheus Biosciences Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Down Syndrome Amyloid Beta-protein

Start date: 2009-06-01
Primary completion: 2011-01-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.